Manufacturing, exporting, and supplying ethical pharmaceutical products with a focus on cardiac and diabetic treatments.
Annual revenue $4.6M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Alodia

Alodia is a company. Alodia offers products and services including Alosar and Alovas.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $4.58 M (USD)
    79.6
    as on Mar 31, 2022
  • Net Profit
    $115.85 K (USD)
    64.46
    as on Mar 31, 2022
  • EBITDA
    $97.19 K (USD)
    77.73
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Alodia

Alodia offers a comprehensive portfolio of products and services, including Alosar and Alovas.

Product name locked
Category locked
Primary

This product is developed as a combination of Losartan Potassium and Amlodipine for managing hypertension and related conditions

Product name locked
Category locked
Locked

This product is formulated as Atorvastatin tablets for addressing cholesterol levels and supporting cardiovascular health

Funding Insights of Alodia

Premium access

Detailed funding history for Alodia

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Alodia

Investments
Premium access

Investment portfolio details for Alodia

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Alodia

Premium access

Detailed financials for Alodia

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Alodia Comparisons

Alodia Primary company
Description
Manufacturing, exporting, and supplying ethical pharmaceutic...
Location
-
Founded Year
-
Annual Revenue
$4.58 M (USD)
Net Profit
$115.85 K (USD)
EBITDA
$97.19 K (USD)
Employees
Not available
Premium access

Peer comparison for Alodia

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Alodia

Premium access

Detailed competitors of Alodia

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Alodia

Premium access

Complete news archive for Alodia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alodia

Annual revenue of Alodia is $4.58M as on Mar 31, 2022.

Alodia is identified as a young and fast-growing ethical pharmaceutical organization that manufactures and exports products for cardiac and diabetic diseases. Research and development efforts are directed towards translating advanced science into effective therapies, emphasizing human responsibilities and ethical practices. The companys mission involves thriving with passion and compassion, while products like Alosar and Alovas are provided to support health needs. Operations are conducted with a commitment to innovation and well-being, ensuring remedies are developed day and night for global supply.

Alodia offers Alosar and Alovas.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available